Phytochemicals as potential chemopreventive and chemotherapeutic agents in hepatocarcinogenesis

European Journal of Cancer Prevention

Volumn 18, Issue 1, 2009, Pages 13-25

  Mann, Christopher D ^a,c   Neal, Christopher P ^a   Garcea, Giuseppe ^b   Manson, Margaret M ^a   Dennison, Ashley R ^b   Berry, David P ^b  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b LEICESTER GENERAL HOSPITAL   (United Kingdom)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Carcinoma; Chemoprevention; Chemotherapeutics; Hepatocellular hEpatocarcinogenesis; Phytochemicals

Indexed keywords

AFLATOXIN; CAFFEIC ACID; CAFFEINE; CAPSAICIN; CATECHIN; CISPLATIN; CURCUMIN; DOXORUBICIN; ELLAGIC ACID; EPIGALLOCATECHIN GALLATE; FLUOROURACIL; GARLIC EXTRACT; GENISTEIN; GERANIOL; LIMONENE; OLTIPRAZ; PERILLYL ALCOHOL; PLANT MEDICINAL PRODUCT; QUERCETIN; RESVERATROL; SILIBININ; SILYMARIN;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; BREAST CANCER; CANCER CELL CULTURE; CANCER COMBINATION CHEMOTHERAPY; CANCER PREVENTION; CANCER SURVIVAL; CELL CYCLE ARREST; CELL CYCLE S PHASE; CELL STRAIN HEPG2; CHEMOPROPHYLAXIS; CLINICAL PRACTICE; CONCENTRATION RESPONSE; DISEASE MARKER; HIGH RISK PATIENT; HUMAN; IN VITRO STUDY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER METASTASIS; LOW DRUG DOSE; NONHUMAN; PATIENT SELECTION; PHYTOCHEMISTRY; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; RECURRENT DISEASE; REVIEW; SKIN CARCINOGENESIS; SKIN CARCINOMA; SURVIVAL TIME; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BRASSICACEAE; CAFFEINE; CAPSAICIN; CARCINOMA, HEPATOCELLULAR; CATECHIN; CHEMOPREVENTION; CURCUMIN; FLAVONOIDS; HUMANS; LIVER NEOPLASMS; PHENOLS; PLANT EXTRACTS; STILBENES;

EID: 58149247844     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e3282f0c090     Document Type: Review

References (201)

1. Aheme SA, O'Brien NM (1999). Protection by the flavonoids myricetin, quercetin, and rutin against hydrogen peroxide-induced DNA damage in Caco-2 and Hep G2 cells. Nutr Cancer 34:160-166.
2. Akagi K, Hirose M, Hoshiya T, Mizoguchi Y, Ito N, Shirai T (1995). Modulating effects of ellagic acid, vanillin and quercetin in a rat medium term multi-organ carcinogenesis model. Cancer Lett 94:113-121.
3. Bae MK, Kim SH, Jeong JW, Lee YM, Kim HS, Kim SR, et al. (2006). Curcumin inhibits hypoxia-induced angiogenesis via down-regulation of HIF-1. Oncol Rep 15:1557-1562.
4. Bailey G, Taylor M, Selivonchick D, Eisele T, Hendricks J, Nixon J, et al. (1982). Mechanisms of dietary modification of aflatoxin B1 carcinogenesis. Basic Life Sci 21:149-165.
5. Bailey GS, Hendricks JD, Shelton DW, Nixon JE, Pawlowski NE (1987). Enhancement of carcinogenesis by the natural anticarcinogen indole-3- carbinol. J Natl Cancer Inst 78:931 -934.
6. Bailey HH, Levy D, Harris LS, Schink JC, Foss F, Beatty P, et al. (2002). A phase II trial of daily perillyl alcohol in patients with advanced ovarian cancer: Eastern Cooperative Oncology Group Study E2E96. Gynecol Oncol 85:464-468.
7. Bammler TK, Slone DH, Eaton DL (2000). Effects of dietary oltipraz and ethoxyquin on aflatoxin B1 biotransformation in non-human primates. Toxicol Sci 54:30-41.
8. Belloir C, Singh V, Daurat C, Siess MH, LeBon AM (2006). Protective effects of garlic sulfur compounds against DNA damage induced by direct- and indirect-acting genotoxic agents in HepG2 cells. Food Chem Toxicol 44:827-834.
9. Berges R, Siess MH, Arnault I, Auger J, Kahane R, Pinnert MF, et al. (2004). Comparison of the chemopreventive efficacies of garlic powders with different alliin contents against aflatoxin B1 carcinogenicity in rats. Carcinogenesis 25:1953-1959.
10. Bolton MG, Munoz A, Jacobson LP, Groopman JD, Masuitenko YY, Roebuck BD, et al. (1993). Transient intervention with oltipraz protects against aflatoxininduced hepatic tumorigenesis. Cancer Res 53:3499-3504.
11. Boonkitticharoen V, Laohathai K, Puribhat S (1993). Differential radiosensitization of radioresistant human cancer cells by caffeine. J Med Assoc Thai 76: 271-277.
12. Boyd JN, Babish JG, Stoewand GS (1982). Modification of beet and cabbage diets of alflatoxin B1 -induced rat plasma alpha-fetoprotein elevation, hepatic tumorigenesis, and mutagenicity of urine. Food Chem Toxicol 20:47-52.
13. Busquets S, Carbo N, Almendro V, Quiles MT, Lopez-Soriano FJ, Argiles JM (2001). Curcumin, a natural product present in turmeric, decreases tumor growth but does not behave as an anticachectic compound in a rat model. Cancer- Lett 167:33-38.
14. Cao J, Xu Y, Chen J, Klaunig JE (1996). Chemopreventive effects of green and black tea on pulmonary and hepatic carcinogenesis. Fundam Appl Toxicol 29:244-250.
15. Carbo N, Costelli P, Baccino FM, Lopez-Soriano FJ, Argiles JM (1999). Resveratrol, a natural product present in wine, decreases tumour growth in a rat tumour model. Biochem Biophys Res Commun 254:739-743.
16. Carrasco-Legleu CE, Marquez-Rosado L, Fattel-Fazenda S, Arce-Popoca E, Perez-Carreon Jl, Villa-Trevino S (2004). Chemoprotective effect of caffeic acid phenethyl ester on promotion in a medium-term rat hepatocarcinogenesis assay. Int J Cancer 108:488-492.
17. 2 /M phase: involvement of ATM activation and upregulation of p21waf1/ cipl and Wee1. Biochem Pharmacol 67:717-276.
18. Chen C, Yu R, Owuor ED, Kong AN (2000). Activation of antioxidant-response element (ARE), mitogen-activated protein kinases (MAPKs) and caspases by major green tea polyphenol components during cell survival and death. Arch Pharm Res 23:605-612.
19. Chen YN, Cheng CC, Chen JC, Tsauer W, Hsu SL (2003). Norcantharidininduced apoptosis is via the extracellular signal-regulated kinase and c-Jun- NH2-terminal kinase signaling pathways in human hepatoma HepG2 cells. Br J Pharmacol 140:461-470.
20. Chen ZY, Yan RQ, Qin GZ, Qin LL (1987). Effect of six edible plants on the development of AFB1-induced gamma-glutamyltranspeptidase-positive hepatocyte foci in rats. Zhonghua Zhong Liu Za Zhi 9:109-111.
21. Chi WJ, Doong SL, Lin-Shiau SY, Boone CW, Kelloff GJ, Lin JK (1998). Oltipraz, a novel inhibitor of hepatitis B virus transcription through elevation of p53 protein. Carcinogenesis 19:2133-2138.
22. Chuang SE, Cheng AL, Lin JK, Kuo ML (2000a). Inhibition by curcumin of diethylnitrosamine-induced hepatic hyperplasia, inflammation, cellular gene products and cell-cycle-related proteins in rats. Food Chem Toxicol 38: 991-995.
23. Chuang SE, Kuo ML, Hsu CH, Chen CR, Lin JK, Lai GM, et al. (2000b). Curcumin-containing diet inhibits diethylnitrosamine-induced murine hepatocarcinogenesis. Carcinogenesis 21:331-335.
24. Chung TW, Moon SK, Chang YC, Ko JH, Lee YC, Cho G, et al. (2004). Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: complete regression of hepatoma growth and metastasis by dual mechanism. FASEB J 18:1670-1681.
25. Ciolino HP, Yeh GC (1999). Inhibition of aryl hydrocarbon-induced cytochrome P-450 1A1 enzyme activity and CYP1A1 expression by resveratrol. Mol Pharmacol 56:760-767.
26. Dashwood RH, Fong AT, Williams DE, Hendricks JD, Bailey GS (1991). Promotion of aflatoxin B1 carcinogenesis by the natural tumor modulator indole-3-carbinol: influence of dose, duration, and intermittent exposure on indole-3-carbinol promotional potency. Cancer Res 51:2362-2365.
27. DeLedinghen V, Monvoisin A, Neaud V, Krisa S, Payrastre B, Bedin C, et al. (2001). Trans-resveratrol, a grapevine-derived polyphenol, blocks hepatocyte growth factor-induced invasion of hepatocellular carcinoma cells. Int J Oncol 19:83-88.
28. Delmas D, Jannin B, Cherkaoui-Malki M, Latruffe N (2000). Inhibitory effect of resveratrol on the proliferation of human and rat hepatic derived cell lines. Oncol Rep 7:847-852.
29. DeMartino A, Filomeni G, Aquilano K, Ciriolo MR, Rotilio G (2006). Effects of water garlic extracts on cell cycle and viability of HepG2 hepatoma cells. J Nutr Biochem 17:742-749.
30. Denda A, Endoh T, Tang Q, Tsujiuchi T, Nakae D, Konishi Y (1998). Prevention by inhibitors of arachidonic acid cascade of liver carcinogenesis, cirrhosis and oxidative DNA damage caused by a choline-deficient, L-amino acid-defined diet in rats. Mutat Res 402:279-288.
31. Dillehay LE, Chang G, Williams JR (1988). Effects of methylxanthines on cellcycle redistribution and sensitization to killing by low-dose-rate radiation. NCI Monogr 6:173-176.
32. Duthie SJ, Johnson W, Dobson VL (1997). The effect of dietary flavonoids on DNA damage (strand breaks and oxidised pyrimdines) and growth in human cells. Mutat Res 39:141-151.
33. Elegbede JA, Elson CE, Qureshi A, Tanner MA, Gould MN (1984). Inhibition of DMBA-induced mammary cancer by the monoterpene o-limonene. Carcinogenesis 5:661-664.
34. El-Mofty MM, Sakr SA, Essawy A, Abdel-Gawad HS (1994). Preventive action of garlic on aflatoxin B1 -induced carcinogenesis in the toad Bufo regularis. Nutr Cancer 21:95-100.
35. Ferenci P, Dragosics B, Drittrich H, Frank H, Benda L, Lochs H, et al. (1989). Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver. J Hepatol 9:105-113.
36. Fukaya Y, Yamaguchi M (2005). Overexpression of regucalcin suppresses apoptotic cell death in the cloned rat hepatoma H4-II-E cells induced by a naturally occurring isothiocyanate sulforaphane. Int J Mol Med 15:853-857.
37. Galati G, O'Brien PJ (2003). Cytoprotective and anticancer properties of coenzyme Q vs. capsaicin. Biofactors 18:195-205.
38. Gallus S, Bertuzzi M, Tavani A, Bosetti C, Negri E, LaVecchia C, et al. (2002). Does coffee protect against hepatocellular carcinoma? Br J Cancer 87: 956-959.
39. Garcea G, Jones DJ, Singh R, Dennison AR, Farmer PB, Sharma RA, et al. (2004). Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration. Br J Cancer 90: 1011-1015.
40. Gelatti U, Covolo L, Francheschini M, Pirali F, Tagger A, Ribero ML, et al. (2005). Coffee consumption reduces the risk of hepatocellular carcinoma independently of its aetiology: a case-control study. J Hepatol 42:528-534.
41. Gentilini MB, Duflo D, Richard-Lenoble G, Brucker M, Danis G, Niel Y, et al. (1980). Assessment of RP35972 (oltipraz a new antischistosomal drug against Schistosoma hematobium, Schistosoma mansoni, and Schistosoma intercalatum. Acta Trop 39:271-274.
42. Gharavi N, El-Kadi AO (2005). Tert-butylhydroquinone is a novel aryl hydrocarbon receptor ligand. Drug Metab Dispos 33:365-372.
43. Giri RK, Parija T, Das BR (1999). D-limonene chemoprevention of hepatocarcinogenesis in AKR mice: inhibition of c-jun and c-myc. Oncol Rep 6: 1123-1127.
44. Godlewski CE, Boyd JN, Shreman WK, Anderson JL, Stoewsand GS (1985). Hepatic glutathione S-transferase activity and aflatoxin B1-induced enzyme altered foci in rats fed fractions of Brussels sprouts. Cancer Lett 28:151-157.
45. Gu Y, Zhu CF, Iwamoto H, Chen JS (2005). Genistein inhibits invasive potential of human hepatocellular carcinoma by altering cell cycle, apoptosis, and angiogenesis. World J Gastroenterol 11:6512-6517.
46. Guyonnet D, Berges R, Siess MH, Pinnert MF, Chagnon MC, Suschetet M, et al. (2004). Post-initiation modulating effects of allyl sulfides in rat hepatocarcinogenesis. Food Chem Toxicol 42:1479-1485.
47. Haag JD, Gould MN (1994). Mammary carcinoma regression induced by perillyl alcohol, a hydroxylated analog of limonene. Cancer Chemother Pharmacol 34:477-483.
48. Haber-Mignard D, Suschetet M, Berges R, Astorg R Siess MH (1996). Inhibition of aflatoxin B1- and W-nitrosodiethylamine-induced liver preneoplastic foci in rats fed naturally occurring allyl sulfides. Nutr Cancer 25:61-70.
49. Hammons GJ, Fletcher JV, Stepps KR, Smith EA, Balentine DA, Harbowy ME, et al. (1999). Effects of chemoprotective agents on the metabolic activation of the carcinogenic arylamines PhIP and 4-aminobiphenyl in human and rat liver microsomes. Nutr Cancer 33:46-52.
50. Hayes MA, Rushmore TH, Goldberg MT (1987). Inhibition of hepatocarcinogenic responses to 1,2-dimethylhydrazine by diallyl sulfide, a component of garlic oil. Carcinogenesis 8:1155-1157.
51. Hirose M, Hasegawa R, Kimura J, Akagi K, Yoshida Y, Tanaka H, et al. (1995). Inhibitory effects of 1-0-hexyl-2,3,5-trimethylhydroquinone (HTHQ), green tea catechins and other antioxidants on 2-amino-6- methyldipyrido[1,2-a:3',2'- dlimidazole (Glu-P-1)-induced rat hepatocarcinogenesis and dose-dependent inhibition by HTHQ of lesion induction by Glu-P-1 or 2-amino-3,8- dimethylimidazo[4,5-f]quinoxaline (MelQx). Carcinogenesis 16:3049-3055.
52. Hirose M, Takahashi S, Ogawa K, Futakuchi M, Shirai T (1999a). Phenolics: blocking agents for heterocyclic amine-induced carcinogenesis. Food Chem Toxicol 37:985-992.
53. Hirose M, Takahashi S, Ogawa K, Futakuchi M, Shirai T, Shibutani M, et al. (1999b). Chemoprevention of heterocyclic amine-induced carcinogenesis by phenolic compounds in rats. Cancer Lett 143:173-178.
54. Hirose M, Yamaguchi T, Kimoto N, Ogawa K, Futakuchi M, Sano M, et al. (1998). Strong promoting activity of phenylethyl isothiocyanate and benzyl isothiocyanate on urinary bladder carcinogenesis in F344 male rats. Int J Cancer 77:773-777.
55. Hosaka S, Kawa S, Aoki Y, Tanaka E, Yoshizawa K, Karasawa Y, et al. (2001). Hepatocarcinogenesis inhibition by caffeine in AQ rats treated with 2- acetylaminofluorene. Food Chem Toxicol 39:557-561.
56. Howells LM, Moiseeva EP, Neal CP, Foreman BE, Andreadi CK, Sun Y, et al. (2007). Predicting the physiological relevance of in vitro cancer preventive activities of phytochemicals. Acta Pharmacol Sin 28; 1274-304.
57. Hwang ES, Jeffrey EH (2005). Induction of quinone reductase by sulforaphane and sulforaphane N-acetylcysteine conjugate in murine hepatoma cells. J Med Food 8:198-203.
58. Hwang ES, Lee HJ (2006a). Allyl isothiocyanate and its N-acetylcysteine conjugate suppress metastasis via inhibition of invasion, migration, and matrix metalloproteinase-2/-9 activities in SK-Hep 1 human hepatoma cells. Exp Biol Med (Maywood) 231:421 -430.
59. Hwang ES, Lee HJ (2006b). Induction of quinone reductase by allylisothiocyanate (AITC) and the N-acetylcysteine conjugate of AlTC in Hepa1c1c7 mouse hepatoma cells. Biofactors 26:7-15.
60. Hwang ES, Lee HJ (2006c). Phenylethyl isothiocyanate and its N-acetylcysteine conjugate suppress the metastasis of SK-Hep1 human hepatoma cells. J Nutr Biochem 17:837-846.
61. IARC (2004). Cruciferous vegetables, isthiocyanates and indoles. Geneva: International Agency for Research on Cancer Press.
62. Iciek MB, Rokita HB, Wlodek LB (2001). Effects of diallyl disulfide and other donors of sulfane sulfur on the proliferation of human hepatoma cell line (HepG2). Neoplasma 48:307-312.
63. Inoue M, Yoshimi I, Sobue T, Tsugane S (2005). Influence of coffee drinking on subsequent risk of hepatocellular carcinoma: a prospective study in Japan. J Natl Cancer Inst 97:293-300.
64. Ito N, Hiasa Y, Konishi Y, Marugami M (1969). The development of carcinoma in liver of rats treated with m-toluylenediamine and the synergistic and antagonistic effects with other chemicals. Cancer Res 29:1137-1145.
65. Jacobson LP, Zhang BC, Zhu YR, Wang JB, Zhang QN, Yu LY, et al. (1997). Oltipraz chemoprevention trial in Qidong, People's Republic of China: study design and clinical outcomes. Cancer Epidemiol Biomarkers Prev 6: 257-265.
66. Jang JJ, Cho KJ, Lee YS, Bae JH (1991). Different modifying responses of capsaicin in a wide-spectrum initiation model of F344 rat. J Korean Med Sci 6:31-36.
67. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, et al. (1997). Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275:218-220.
68. Jiang MC, Yang-Yen H, Yen JJ, Lin JK (1996). Curcumin induces apoptosis in immortalized NIH 3T3 and malignant cancer cell lines. Nutr Cancer 26: 111-120.
69. Jin UH, Chung TW, Kang SK, Suh SJ, Kim JK, Chung KH, et al. (2005). Caffeic acid phenyl ester in propolis is a strong inhibitor of matrix metalloproteinase-9 and invasion inhibitor: isolation and identification. Clin Chim Acta 362: 57-64.
70. Jung MY, Kang HJ, Moon A (2001). Capsaicin-induced apoptosis in SK-Hep-1 hepatocarcinoma cells involves Bcl-2 downregulation and caspase-3 activation. Cancer Lett 165:139-145.
71. Kaji I, Tatsuta M, lishi H, Bada M, Inoue A, Kasugai H (2001). Inhibition by o-limonene of experimental hepatocarcinogenesis in Sprague-Dawley rats does not involve p21(ras) plasma membrane association. Int J Cancer 93:441-444.
72. Kang ZC, Tsai SJ, Lee H (1999). Quercetin inhibits benzotalpyrene-induced DNA adducts in human Hep G2 cells by altering cytochrome P-450 1A1 gene expression. Nutr Cancer 35:175-179.
73. Kassie F, Uhl M, Grasl-Kraupp B, Verkerk R, Kundi M, Chabicovsky M, et al. (2003). Chemoprevention of 2-amino-3-methylimidazo(4,5-f]quinoline (IQ)- induced colonic and hepatic preneoplastic lesions in the Fischer 344 rat by cruciferous vegetables administered simultaneously with the carcinogen. Carcinogenesis 24:255-261.
74. Kensler TW, Egner PA, Dolan PM, Groopman JD, Roebuck BD (1987). Mechanism of protection against aflatoxin tumongenicity in rats fed 5(2- pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) and related 1,2-dithiol-3- thiones and 1,2-dithiol-3-ones. Cancer Res 47:4271-4277.
75. Kensler TW, Chen JG, Egner PA, Fahey JW, Jacobson LP, Stephenson KK, et al. (2005). Effects of glucosinolate-rich broccoli sprouts on urinary levels of aflatoxin-DNA adducts and phenanthrene tetraols in a randomized clinical trial in He Zuo township, Qidong, People's Republic of China. Cancer Epidemiol Biomarkers Prev 14(11 Pt 1):2605-2613.
76. Kim SH, Lee CS (1992). The effect of caffeine on diethylnitrosamine- initiated hepatic altered foci in a mid-term induction system. In vivo 6:223-226.
77. Kim DJ, Lee KK, Han BS, Ahn B, Bae JH, Jang JJ (1994). Biphasic modifying effect of indole-3-carbinol on diethylnitrosamine-induced preneoplastic glutathione S-transferase placental form-positive liver cell foci in Sprague- Dawley rats. Jpn J Cancer Res 85:578-583.
78. Kim DJ, Han BS, Ahn B, Hasegawa R, Shirai T, Ito N, et al. (1997). Enhancement by indole-3-carbinol of liver and thyroid gland neoplastic development in a rat medium-term multiorgan carcinogenesis model. Carcinogenesis 18: 377-381.
79. Kim HJ, Chang EJ, Bae SJ, Shim SM, Park HD, Rhee CH, et al. (2002). Cytotoxic and antimutagenic stilbenes from seeds of Paeonia lactiflora. Arch Pharm Res 25:293-299.
80. + release pathway mediates the capsaicin-induced apoptosis in HepG2 human hepatoma cells. Arch Pharm Res 28:73-80.
81. Kocsis Z, Marcsek ZL, Jakab MG, Szende B, Tompa A (2005). Chemopreventive properties of trans-resveratrol against the cytotoxicity of chloroacetanilide herbicides in vitro. Int J Hyg Environ Health 208:211 -218.
82. Kohno H, Tanaka T, Kawabata K, Hirose Y, Sugie S, Tsuda H, et al. (2002). Silymann, a naturally occurring polyphenolic antioxidant flavonoid, inhibits azoxymethane induced colon carcinogenesis in male F344 rats. Int J Cancer 101:461-468.
83. Kojima T, Tanaka T, Mori H (1994). Chemoprevention of spontaneous endometrial cancer in female Donryu rats by dietary indole-3-carbinol. Cancer Res 54:1446-1449.
84. Kozuki Y, Miura Y, Yagasaki K (2001). Resveratrol suppresses hepatoma cell invasion independently of its anti-prolrferative action. Cancer Lett 167:151 -156.
85. Kuo PL, Lin CC (2003). Green tea constituent (-)-epigallocatechin-3- gallate inhibits Hep G2 cell proliferation and induces apoptosis through p53- dependent and Fas-mediated pathways. J Biomed Sci 10:219-227.
86. Kuo PL Chiang LC, Lin CC (2002). Resveratrol-induced apoptosis is mediated by p53-dependent pathway in Hep G2 cells. Life Sci 72:23-34.
87. Kuribayashi M, Asamoto M, Suzuki S, Hokaiwado N, Ogawa K, Shirai T (2006). Lack of modification of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MelQx) rat hepatocarcinogenesis by caffeine, a CYP1A2 inducer, points to complex counteracting influences. Cancer Lett 232:289-299.
88. Kurozawa Y, Ogimoto I, Shibata A, Nose T, Yoshimura T, Suzuki H, et al. (2004). Dietary habits and risk of death due to hepatocellular carcinoma in a large scale cohort study in Japan. Univariate analysis of JACC study data. Kurume Med J 51:141-149.
89. Kweon S, Park KA, Choi H (2003). Chemopreventive effect of garlic powder diet in diethylnitrosamine-induced rat hepatocarcinogenesis. Life Sci 73: 2515-2526.
90. Lagopoulos L, Sunahara Gl, Wurzner H, Fliesen T, Stalder R (1991). The correlation of body growth with diethylnitrosamine-induced hepatocarcinogenesis in relation to serum insulin and somatomedin-C. Carcinogenesis 12:211-215.
91. Lea MA, Liao Q, Sadhukhan AK, Cottle S, Wang 2Y, Yang CS (1993). Inhibitory effects of tea extracts and (-)-epigallocatechin gallate on DNA synthesis and proliferation of hepatoma and erythroleukemia cells. Cancer Lett 68:231-236.
92. Lee JK, Choi EH, Lee KG, Chun HS (2005). Alleviation of aflatoxin B1-induced oxidative stress in HepG2 cells by volatile extract from Allii Fistulosi Bulbus. Life Sci 77:2896-2910.
93. Lee YS (2005). Role of NADPH oxidase-mediated generation of reactive oxygen species in the mechanism of apoptosis induced by phenolic acids in HepG2 human hepatoma cells. Arch Pharm Res 28:1183-1189.
94. Lee YS, Kang YS, Lee JS, Nicolova S, Kim JA (2004). Involvement of NADPH oxidase-mediated generation of reactive oxygen species in the apototic cell death by capsaicin in HepG2 human hepatoma cells. Free Radic Res 38:405-412.
95. Lei B, Roncaglia V, Vigano R, Cremonini C, DeMaria N, Buono MGD, et al. (2002). Phytoestrogens and liver disease. Mol Cell Endocrinol 193:81-84.
96. Li H, Che Y, Tang W (2002). Effect of curcumin on proliferation and apoptosis in human hepatic cells. Zhonghua Gan Zang Bing Za Zhi 10:449-451.
97. Li L, Braiteh FS, Kurzrock R (2005). Liposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis. Cancer 104:1322-1331.
98. Li Y (1991). Comparative study on the inhibitory effect of green tea, coffee and levamisole on the hepatocarcinogenic action of diethylnitrosamine. Zhonghua Zhong Liu Za Zhi 13:193-195.
99. Li Y, Su J, Qin L, Egner PA, Wang J, Groopman JD, et al. (2000). Reduction of aflatoxin B(1) adduct biomarkers by oltipraz in the tree shrew (Tupaia belangeri chinensis). Cancer Lett 154:79-83.
100. Lin LI, Ke YF, Ko YC, Lin JK (1998). Curcumin inhibits SK-Hep-1 hepatocellular carcinoma cell invasion in vitro and suppresses matrix metalloproteinase-9 secretion. Oncology 55:249-253.
101. Liu G, Oettel K, Bailey H, Ummersen LV, Tutsch K, Staab MJ, et al. (2003a). Phase II trial of perillyl alcohol (NSC 641066) administered daily in patients with metastatic androgen independent prostate cancer. Invest New Drugs 21:367-372.
102. Liu HS, Pan CE, Yang W, Liu XM (2003b). Antitumor and immunomodulatory activity of resveratrol on experimentally implanted tumor of H22 in Balb/c mice. World J Gastroenterol 9:1474-1476.
103. Lopez-Carrillo L, Hernandez AM, Dubrow R (1994). Chilli pepper consumption and gastric cancer in Mexico. Am J Epidem 139:263-271.
104. Low-Baselli A, Huber WW, Kafer M, Bukowska K, Schurte-Hermann R, Gra81-Kraupp B (2000). Failure to demonstrate chemoprevention by the monoterpene perillyl alcohol during early rat hepatocarcinogenesis: a cautionary note. Carcinogenesis 21:1869-1877.
105. Luo H, Tang L, Tang M, Billam M, Huang T, Yu J, et al. (2006). Phase lla chemoprevention trial of green tea polyphenols in high-risk individuals of liver cancer: modulation of urinary excretion of green tea polyphenols and 8-hydroxydeoxyguanosine. Carcinogenesis 27:262-268.
106. Ma XD, Yan F, Ma AD, Wang HJ (2006). Resveratrol induces HepG2 cell apoptosis by depolarizing mitochondrial membrane. Nan Fang Yi Ke Da Xue Xue Bao 26:406-408.
107. Manson MM, Hudson EA, Ball HW, Barrett MC, Clark HL, Judah DJ, et al. (1998). Chemoprevention of aflatoxin B1-induced carcinogenesis by indole-3- carbinol in rat liver: predicting the outcome using early biomarkers. Carcinogenesis 19:1829-1836.
108. Matsumoto N, Kohri T, Okushio K, Hara Y (1996). Inhibitory effects of tea catechins, black tea extract and oolong tea extract on hepatocarcinogenesis in rat. Jpn J Cancer Res 87:1034-1038.
109. Maxuitenko YY, MacMillan DL, Kensler TW, Roebuck BD (1993). Evaluation of the post-initiation effects of oltipraz on aflatoxin B1-induced preneoplastic foci in a rat model of hepatic tumorigenesis. Carcinogenesis 14:2423-2425.
110. Meadows SM, Mulkerin D, Berlin J, Bailey H, Kolesar J, Warren D, et al. (2002). Phase II trial of perillyl alcohol in patients with metastatic colorectal cancer. Int J Gastrointest Cancer 32:125-128.
111. Mills JJ, Chari RS, Boyer U, Gould MN, Jirtle RL (1995). Induction of apoptosis in liver tumors by the monoterpene perillyl alcohol. Cancer Res 55:979-983.
112. Miura D, Miura Y, Yagasaki K (2003). Hypolipidemic action of dietary resveratrol, a phytoalexin in grapes and red wine, in hepatoma-bearing rats. Life Sci 73:1393-1400.
113. Miura D, Miura Y, Yagasaki K (2004a). Resveratrol inhibits hepatoma cell invasion by suppressing gene expression of hepatocyte growth factor via its reactive oxygen species-scavenging property. Clin Exp Metastasis 21:445-451.
114. Miura Y, Ono K, Okauchi R, Yagasaki K (2004b). Inhibitory effect of coffee on hepatoma proliferation and invasion in culture and on tumor growth, metastasis and abnormal lipoprotein profiles in hepatoma-bearing rats. J Nutr Sci Vitaminol (Tokyo) 50:38-44.
115. Morse MA, LaGreca SD, Amin SG, Chung FL (1990). Effects of indole-3-carbinol on lung tumorigenesis and DNA methylation induced by 4-(methylnitrosamino)-1-(3-pyridyl)-l-butanone (NNK) and on the metabolism and disposition of NNK in A/J mice. Cancer Res 50:2613-2617.
116. Mousavi Y, Adlercreutz H (1993). Genistein is an effective stimulator of sex hormone-binding globulin production in hepatocarcinoma human liver cancer cells and suppresses proliferation of these cells in culture. Steroids 58:301-304.
117. Mu LN, Zhou XF, Ding BG, Wang RH, Zhang ZF, Chen CW, et al. (2003). A case-control study on drinking green tea and decreasing risk of cancers in the alimentary canal among cigarette smokers and alcohol drinkers. Zhonghua Liu Xing Bing Xue Za Zhi 24:192-195.
118. Nishida H, Omori M, Fukutomi Y, Ninomiya M, Nlshiwaki S, Suganuma M, et al. (1994). Inhibitory effects of (-)-epigallocatechin gallate on spontaneous hepatoma in C3H/HeNCrj mice and human hepatoma-derived PLC/PRF/5 cells. Jpn J Cancer Res 85:221-225.
119. Nishikawa A, Furukawa F, Imazawa T, Ikezaki S, Hasegawa T,Takahashi M (1995). Effects of caffeine on glandular stomach carcinogenesis induced in rats by Nmethyl-N-nitro-N-nitrosoguanidine and sodium chloride. Food Chem Toxicol 33:21-26.
120. Nishikawa T, Nakajima T, Moriguchi M, Jo M, Sekoguchi S, Ishii M, et al. (2006). A green tea polyphenol, epigalocatechin-3-gallate, induces apoptosis of human hepatocellular carcinoma, possibly through inhibition of Bel-2 family proteins. J Hepatol 44:1074-1082.
121. Notarbartolo M, Poma P, Perri D, Dusonchet L, Cervello M, D'Alessandro N (2005). Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells. Analysis of their possible relationship to changes in NF-kB activation levels and in IAP gene expression. Cancer Lett 224:53-65.
122. Oganesian A, Hendricks JD, Pereira CB, Orner GA, Bailey GS, Williams DE (1999). Potency of dietary indole-3-carbinol as a promoter of aflatoxin B1- initiated hepatocarcinogenesis: results from a 9000 animal tumor study. Carcinogenesis 20:453-458.
123. Oganesian A, Hendricks JD, Williams DE (1997). Long term dietary indole-3- carbinol inhibits diethylnitrosamine-initiated hepatocarcinogenesis in the infant mouse model. Cancer Lett 118:87-94.
124. Ogawa K, Hirose M, Sugiura S, Cui L, Imaida K, Ogiso T, et al. (2001). Dosedependent promotion by phenylethyl isothiocyanate, a known chemopreventer, of two-stage rat urinary bladder and liver carcinogenesis. Nutr Cancer 40:134-139.
125. Ohashi Y, Tsuchiya Y, Koizumi K, Sakurai H, Saiki I (2003). Prevention of intrahepatic metastasis by curcumin in an orthotopic implantation model. Oncology 65:250-258.
126. Ong TP, Heidor R, DeConti A, Dagli ML, Moreno FS (2006). Farnesol and geraniol chemopreventive activities during the initial phases of hepatocarcinogenesis involve similar actions on cell proliferation and DNA damage, but distinct actions on apoptosis, plasma cholesterol and HMGCoA reductase. Carcinogenesis 27:1194-1203.
127. Park KA, Kweon S, Choi H (2002). Anticarcinogenic effect and modification of cytochrome P450 2E1 by dietary garlic powder in diethylnitrosamine-initiated rat hepatocarcinogenesis. J Biochem Mol Biol 35:615-622.
128. Park WH, Kim SH, Kim CH (2005). A new matrix metalloproteinase-9 inhibitor 3,4-dihydroxycinnamic acid (caffeic acid) from methanol extract of Euonymus alatus: isolation and structure determination. Toxicology 207: 383-390.
129. Pereira MA (1995). Chemoprevention of diethylnitrosamine-induced liver foci and hepatocellular adenomas in C3H mice. Anticancer Res 15(5B):1953-1956.
130. Qin G, Gopalan-Kriczky P, Su J, Ning Y, Lotlikar PD (1997). Inhibition of aflatoxin B1 -induced initiation of hepatocarcinogenesis in the rat by green tea. Cancer Lett 112:149-154.
131. Qin G, Ning Y, Lotlikar PD (2000). Chemoprevention of aflatoxin B1 -initiated and carbon tetrachloride-promoted hepatocarcinogenesis in the rat by green tea. Nutr Cancer 38:215-222.
132. Ramakrishnan G, Raghavendran HR, Vinodhkumar R, Devaki T (2006). Suppression of N-nitrosodiethylamine induced hepatocarcinogenesis by silymarin in rats. Chem Biol Interact 161:104-114.
133. Ramos S, Alia M, Bravo L, Goya L (2005). Comparative effects of food-derived polyphenols on the viability and apoptosis of a human hepatoma cell line (HepG2). J Agric Food Chem 53:1271-1280.
134. Ravindranath MH, Muthugounder S, Presser N, Viswanathan S (2004). Anticancer therapeutic potential of soy isoflavone, genistein. Adv Exp Med Biol 546:121-165.
135. Roebuck BD, Liu YL, Rogers AE, Groopman JD, Kensler TW (1991). Protection against aflatoxin B1 -induced hepatocarcinogenesis in F344 rats by 5-(2- pyrazinyl)-4-methyl-1,2-dithiole-3-thione (oltipraz): predictive role for shortterm molecular dosimetry. Cancer Res 51:5501 -5506.
136. Rose P, Whiteman M, Huang SH, Halliwell B, Ong CN (2003). Beta-phenylethyl isothiocyanate-mediated apoptosis in hepatoma HepG2 cells. Cell Mot Life Soi 60:1489-1503.
137. Rose P, Armstrong JS, Chua YL, Ong CN, Whiteman M (2005). Beta-phenylethyl isothiocyanate mediated apoptosis; contribution of Bax and the mitochondrial death pathway. Int J Biochem Cell Biol 37:100-119.
138. Rothwell K (1974). Dose-related inhibition of chemical carcinogenesis in mouse skin by caffeine. Nature 252:69-70.
139. Sadek I, Abdel-Salem F, Al-Qattan K (1995). Chemopreventive effects of cabbage on 7,12-dimethylbenz(a)-anthracene-induced hepatocarcinogenesis in toads (Bufo viridis). J Nutr Sci Vitaminol (Tokyo) 41:163-168.
140. Samaranayake MD, Wickramasinghe SM, Wngunawela P, Jayasekera S, Iwai S, Fukushima S (2000). Inhibition of chemically induced liver carcinogenesis in Wistar rats by garlic (Allium sativum). Phytother Res 14:564-567.
141. Sanchez-Perez Y, Carrasco-Legleu C, Garcia-Cuellar C, Perez-Carreon J, Hemandez-Garcia S, Salcido-Neyoy M, et al. (2005). Oxidative stress in carcinogenesis. Correlation between lipid peroxidation and induction of preneoplastic lesions in rat hepatocarcinogenesis. Cancer Lett 217: 25-32.
142. Sharma RA, Gescher AJ, Steward WP (2005). Curcumin: the story so far. Eur J Cancer 41:1955-1968.
143. Shimazu T, Tsubono Y, Kuriyama S, Ohmori K, Koizumi Y, Nishino Y, et al. (2005). Coffee consumption and the risk of primary liver cancer: pooled analysis of two prospective studies in Japan. Int J Cancer 116:150-154.
144. Shukla Y, Arora A (2003). Suppression of altered hepatic foci development by curcumin in wistar rats. Nutr Cancer 25:53-59.
145. Shukla Y, Kalra N, Katiyar S, Siddiqui IA, Arora A (2004). Chemopreventive effect of indole-3-carbinol on induction of preneoplastic altered hepatic foci. Nutr Cancer 50:214-220.
146. Sidransky H, Ito N, Verney E (1966). Influence of alpfia-naphthyl- isothiocyanate on liver tumorigenesis in rats ingesting ethionine and N-2-fluorenylacetamide. J Natl Cancer Inst 37:677-686.
147. Siegers CP, Steffen B, Robke A, Pentz R (1999). The effects of garlic preparations against human tumor cell proliferation. Phytomedicine 6:7-11.
148. Siemann EH, Creasy LL (1992). Concentration of the phytoalexin resveratrol in wine. Am J Eno Vitic 43:49-52.
149. Singh A, Arora A, Shukla Y (2004). Modulation of altered hepatic foci induction by diallyl sulphide in Wistar rats. Eur J Cancer Prev 13:263-269.
150. Singh RP, Dhanalakshma S, Tyagi AK, Chang DC, Agarwal C, Agarwal R (2002). Dietary feeding of silibinin inhibits advance human prostate carcinoma growth in athymic nude mice and increases plasma insulin-like growth factor-binding protein-3 levels. Cancer Res 62:3063-3069.
151. Sofowora GG, Choo EF, Mayo G, Shyr Y, Wilkinson GR (2001). In vivo inhibition of human CYP1A2 activity by oltipraz. Cancer Chemother Pharmacol 47:505-510.
152. Soni KB, Lahiri M, Chackradeo P, Bhide SV, Kuttan R (1997). Protective effect of food additives on aflatoxin-induced mutagenicity and hepatocarcinogenicity. Cancer lett 115:129-133.
153. Sreepriva M, Bali G (2005). Chemopreventive effects of embelin and curcumin against N-nitrosodiethylamine/phenobarbital-induced hepatocarcinogenesis in Wistar rats. Filoterapia 76:549-555.
154. Stark MJ, Burke YD, McKinzie JH, Ayoubi AS, Crowell PL (1995). Chemotherapy of pancreatic cancer with the monoterpene perillyl alcohol. Cancer Lett 96:15-21.
155. Stearns V, Coop A, Singh B, Gallagher A, Yamauchi H, Lieberman R, et al. (2004). A pilot surrogate end point biomarker trial of perillyl alcohol in breast neoplasia. Clin Cancer Res 10:7583-7591.
156. Stoner G, Casto B, Roebuck B, Pereira C, Bailey G (2002). Development of a multi-organ rat model for evaluating chemopreventive agents: efficacy of indole-3-carbinol. Carcinogenesis 23:265-272.
157. Su SJ, Chow NH, Kung ML, Hung TC, Chang KL (2003). Effects of soy isoflavones on apoptosis induction and G2-M arrest in human hepatoma cells involvement of caspase-3 activation, Bcl-2 and Bcl-XL downregulation, and Cdc2 kinase activity. Nutr Cancer 45:113-123.
158. Sun ZJ, Pan CE, Liu HS, Wang GJ (2002). Anti-hepatoma activity of resveratrol in vitro. World J Gastroenterol 8:79-81.
159. Takada N, Matsuda T, Otoshi T, Yano Y, Otani S, Hasegawa T, et al. (1994). Enhancement by organosulfur compounds from garlic and onions of diethylnitrosamine-induced glutathione S-transferase positive foci in the rat liver. Cancer Res 54:2895-2899.
160. Takada N, Yano Y, Wanibuchi H, Otani S, Fukushima S (1997). S-methylcysteine and cysteine are inhibitors of induction of glutathione S-transferase placental form-positive foci during initiation and promotion phases of rat hepatocarcinogenesis. Jpn J Cancer Res 88:435-442.
161. Takahashi S, Hakoi K, Yada H, Hirose M, Ito N, Fukushima S (1992). Enhancing effects of diallyl sulfide on hepatocarcinogenesis and inhibitory actions of the related diallyl disulfide on colon and renal carcinogenesis in rats. Carcinogenesis 13:1513-1518.
162. Takeda M, Ku Y, Toyama H, Suzuki Y, Kuroda Y (2002). Suppressive effects of tea polyphenol and conformational changes with receptor for advanced glycation end products (RAGE) expression in human hepatoma cells. Hepatogastroenterology 49:928-931.
163. Tamura K, Nakae D, Horiguchi K, Akai H, Kobayashi Y, Satoh H, et al. (1997). Inhibition by green tea extract of diethylnitrosamine-initiated but not cholinedeficient, L-amino acid-defined diet-associated development of putative preneoplastic, glutathione S-transferase placental form-positive lesions in rat liver. Jpn J Cancer Res 88:356-362.
164. Tanaka T, Iwata H, Niwa K, Mori Y, Mori H (1988). Inhibitory effect of ellagic acid on N-2-fluorenylacetamide-induced liver carcinogenesis in male ACI/N rats. Jpn J Cancer Res 79:1297-1303.
165. Tanaka T, Mori Y, Morishita Y, Hara A, Ohno T, Kojima T, et al. (1990a). Inhibitory effect of sinigrin and indole-3-carbinol on diethylnitrosamine-induced hepatocarcinogenesis in male ACI/N rats. Carcinogenesis 11:1403-1406.
166. Tanaka T, Nishikawa A, Shima H, Sugie S, Shinoda T, Yoshimi N, et al. (1990b). Inhibitory effects of chlorogenic acid, reserpine, polyprenoic acid (E-5166), or coffee on hepatocarcinogenesis in rats and hamsters. Basic Life Sci 52:429-440.
167. Tang Q, Denda A, Tsujiuchi T, Tsutsumi M, Amanuma T, Murata Y, et al. (1993). Inhibitory effects of inhibitors of arachidonic acid metabolism on the evolution of rat liver preneoplastic foci into nodules and hepatocellular carcinomas with or without phenobarbital exposure. Jpn J Cancer Res 84:120-127.
168. Thapliyal R, Naresh KN, Rao KV, Maru GB (2003). Inhibition of nitrosodiethylamine-induced hepatocarcinogenesis by dietary turmeric in rats. Toxicol Lett 139:45-54.
169. Theiss JC, Shimkin MB (1978). Inhibiting effect of caffeine on spontaneous and urethan-induced lung tumors in strain A mice. Cancer Res 38:1757-1761.
170. Tiedink HGM, Davies JAR, Visser NA, Jongen WMF, van Braekhoven LW (1989). The stability of the nitrosated products of indole, indole-3-acetonitrile, indole- 3-carbinol and 4-chloroindole. Food Chem Toxicol 27:723-730.
171. Tsuda H, Uehara N, Iwahori Y, Asamoto M, ligo M, Nagao M, et al. (1994). Chemopreventive effects of beta-carotene, alpha-tocopherol and five naturally occurring antioxidants on initiation of hepatocarcinogenesis by 2-amino-3-methylimidazo[4,5-f]quinoline in the rat. Jpn J Cancer Res 85(12):1214-1219.
172. Uda N, Kashimoto N, Sumioka I, Kyo E, Sumi S, Fukushima S (2006). Aged garlic extract inhibits development of putative preneoplastic lesions in rat hepatocarcinogenesis. J Nutr 136:855S-860S.
173. Umemura T, Kai S, Hasegawa R, Kanki K, Kitamura Y, Nishikawa A, et al. (2003). Prevention of dual promoting effects of pentachlorophenol, an environmental pollutant, on diethylnitrosamine-induced hepato- and cholangiocarcinogenesis in mice by green tea infusion. Carcinogenesis 24:1105-1109.
174. VanderPloeg LC, Welsch CW (1991). Inhibition by caffeine of ovarian hormoneinduced mammary gland tumorigenesis in female GR mice. Cancer Lett 56:245-250.
175. Van-Rijn J, Van-den-Berg J (1997). Ravonoids as enhancers of x-ray-induced cell damage in hepatoma cells. Clin Cancer Res 3:1775-1779.
176. Varghese L, Agarwal C, Tyagi A, Singh RP, Agarwal R (2005). Silibinin efficacy against human hepatocellular carcinoma. Clin Cancer Res 11: 8441-8448.
177. Vigushin DM, Poon GK, Boddy A, English J, Halbert GW, Pagonis C, et al. (1998). Phase I and pharmacokinetic study of D-limonene in patients with advanced cancer. Cancer Research Campaign Phase l/ll Clinical Trials Committee. Cancer Chemother Pharmacol 42:111 -117.
178. Wang JS, Shen X, He X, Zhu YR, Zhang BC, Wang JB, et al. (1999). Protective alterations in phase 1 and 2 metabolism of aflatoxin B1 by oltipraz in residents of Qidong, People's Republic of China. J Natl Cancer Inst 91:347-354.
179. Watanabe T, Sugie S, Okamoto K, Rahman KM, Ushida J, Mori H (2001). Chemopreventive effects of scordinin on diethylnitrosamine and phenobarbi tal-induced hepatocarcinogenesis in male F344 rats. Jpn J Cancer Res 92:603-609.
180. Wattenberg LW, Coccia JB (1991). Inhibition of 4-(methylnitrosamino)-1- (3- pyridyl)-1 -butanone carcinogenesis in mice by D-limonene and citrus fruit oils. Carcinogenesis 12:115-117.
181. Wattenberg LW, Loub ED (1978). Inhibition of polycyclic aromatic hydrocarboninduced neoplasia by naturally occurring indoles. Cancer Res 38: 1410-1413.
182. Wei DZ, Yang JY, Liu JW, Tong W (2003). Inhibition of liver cancer cell proliferation and migration by a combination of (-)-epigallocatechin-3-gallate and ascorbic acid. J Chemother 15:591-595.
183. Wen J, Zhang Y, Chen X, Shen L, Li GC, Xu M (2004). Enhancement of diallyl disulfide-induced apoptosis by inhibitors of MAPKs in human HepG2 hepatoma cells. Biochem Pharmacol 68:323-331.
184. Williams GM (1994). Interventive prophylaxis of liver cancer. Eur J Cancer Prev 3:89-99.
185. Wu BW, Wu Y, Wang JL, Lin JS, Yuan SY, Cui WR (2003). Study on the mechanism of epidermal growth factor-induced proliferation of hepatoma cells. World J Gastroenterol 9:271 -275.
186. Wu CC, Chung CJ, Tsai SJ, Yang JH, Sheen LY (2004a). Differential effects of allyl sulfides from garlic essential oil on cell cycle regulation in human liver tumor cells. Food Chem Toxicol 42:1937-1947.
187. Wu SL, Sun ZJ, Yu L, Meng KW, Qin XL, Pan CE (2004b). Effect of resveratrol and in combination with 5-FU on murine liver cancer. World J Gastroenterol 10:3048-3052.
188. Wu SJ, Ng LT, Lin CC (2005). Effects of antioxidants and caspase-3 inhibitor on the phenylethyl isothiocyanate-induced apoptotic signaling pathways in human PLC/PRF/5 cells. Eur J Pharmacol 518:96-106.
189. Yen CT, Yen GC (2005). Effect of sulforaphane on metallothionein expression and induction of apoptosis in human hepatoma HepG2 cells. Carcinogenesis 26:2138-2148.
190. Yoysungnoen P, Wirachwong P, Bhattarakosol P, Niimi H, Patumraj S (2005). Antiangiogenic activity of curcumin in hepatocellular carcinoma cells implanted nude mice. Clin Hemorheol Microcirc 33:127-135.
191. Yoysungnoen P, Wirachwong P, Bhattarakosol P, Niimi H, Patumraj S (2006). Effects of curcumin on tumor angiogenesis and biomarkers, COX-2 and VEGF, in hepatocellular carcinoma cell-implanted nude mice. Clin Hemorheol Microcirc 34:109-115.
192. Yu L, Sun ZJ, Wu SL, Pan CE (2003). Effect of resveratrol on cell cycle proteins in murine transplantable liver cancer. World J Gastroenterol 9:2341-2343.
193. Yu SG, Hildebrandt LA, Elson CE (1995). Geraniol, an inhibitor of mevalonate biosynthesis, suppresses the growth of hepatomas and melanomas transplanted to rats and mice. J Nutr 125:2763-2767.
194. Yuan ZP, Chen U, Fan LY, Tang MH, Yang GL, Yang HS, et al. (2006). Liposomal quercetin efficiently suppresses growth of solid tumors in murine models. Clin Cancer Res 12:3193-3199.
195. Zhang G, Miura Y, Yagasaki K (2000a). Induction of apoptosis and cell cycle arrest in cancer cells by in vivo metabolites of teas. Nutr Cancer 38:265-273.
196. Zhang G, Miura Y, Yagasaki K (2000b). Suppression of adhesion and invasion of hepatoma cells in culture by tea compounds through antioxidative activity. Cancer Lett 159:169-173.
197. Zhang G, Miura Y, Yagasaki K (2002). Effects of dietary powdered green tea and theanine on tumor growth and endogenous hyperlipidemia in hepatomabearing rats. Biosci Biotechnol Biochem 66:711-716.
198. Zhang K, Chew M, Yang EB, Wong KP, Mack P (2001). Modulation of cisplatin cytotoxicity and cisplatin-induced DNA cross-links in HepG2 cells by regulation of glutathione-related mechanisms. Mol Pharmacol 59: 837-843.
199. Zhang Q, Tang X, Lu Q, Zhang Z, Rao J, Le AD (2006). Green tea extract and (- )-epigallocatechin-3-gallate inhibit hypoxia- and serum-induced HIF-1 alpha protein accumulation and VEGF expression in human cervical carcinoma and hepatoma cells. Mol Cancer Ther 5:1227-1238.
200. Zhang Q, Tang X, Lu QY, Zhang ZF, Brown J, Le AD (2005). Resveratrol inhibits hypoxia-induced accumulation of hypoxia-inducible factor-1 alpha and VEGF expression in human tongue squamous cell carcinoma and hepatoma cells. Mol Cancer Ther 4:1465-1474.
201. Zi X, Feyes DK, Agarwal R (1998). Anticarcinogenic effect of a flavonoid antioxidant, silymarin, in human breast cancer cells MDA-MB 468: induction of G1 arrest through an increase in Cip1/p21 concomitant with a decrease in kinase activity of cyclin-dependent kinases and associated cyclins. Clin Cancer Res 4:1055-1064.